Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.74 CAD | +5.45% | +15.23% | -29.55% |
Sales 2024 * | 154M 113M | Sales 2025 * | 155M 113M | Capitalization | 42.56M 31.11M |
---|---|---|---|---|---|
Net income 2024 * | -1M -731K | Net income 2025 * | 1M 731K | EV / Sales 2024 * | 0.28 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.28 x |
P/E ratio 2024 * |
-24.3
x | P/E ratio 2025 * |
11.4
x | Employees | 98 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.04% |
Latest transcript on Medexus Pharmaceuticals Inc.
1 day | +5.45% | ||
1 week | +15.23% | ||
Current month | +8.07% | ||
1 month | +11.54% | ||
3 months | -31.76% | ||
6 months | -15.94% | ||
Current year | -29.55% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-10-15 | |
Marcel Konrad
DFI | Director of Finance/CFO | 49 | 21-07-18 |
Richard Labelle
COO | Chief Operating Officer | - | 14-02-17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Adele Gulfo
BRD | Director/Board Member | 61 | 19-06-24 |
Michael Mueller
CHM | Chairman | 64 | 14-05-30 |
Benoit Gravel
BRD | Director/Board Member | - | 17-09-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 1.74 | +5.45% | 143,076 |
24-04-23 | 1.65 | +1.85% | 27,608 |
24-04-22 | 1.62 | -1.82% | 57,642 |
24-04-19 | 1.65 | +6.45% | 74,660 |
24-04-18 | 1.55 | +2.65% | 51,716 |
Delayed Quote Toronto S.E., April 24, 2024 at 03:58 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.55% | 31.01M | |
+25.61% | 660B | |
+22.63% | 562B | |
-5.24% | 358B | |
+16.49% | 322B | |
+8.28% | 297B | |
+13.64% | 219B | |
-9.61% | 196B | |
+6.72% | 199B | |
-8.75% | 149B |
- Stock Market
- Equities
- MDP Stock